Skip to content
10-K

Annual Report

ESSA Pharma Inc.

0001558370-24-016318

← back to feed
Filed
Dec 17, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Dec 16, 2024 44.39M sh
Shares Diluted FY 2024 · Sep 30, 2024 44.28M sh
Shares Diluted FY 2024 · Sep 30, 2023 44.09M sh
Operating Cash Flow FY 2024 · Sep 30, 2024 −$22.72M
Operating Cash Flow FY 2024 · Sep 30, 2023 −$19.78M
Short Term Investments FY 2024 · Sep 30, 2024 $23.05M
Short Term Investments FY 2024 · Sep 30, 2023 $114.37M
Cash And Equivalents FY 2024 · Sep 30, 2024 $103.71M
Cash And Equivalents FY 2024 · Sep 30, 2023 $33.7M
Stockholders Equity FY 2024 · Sep 30, 2024 $124.61M
Stockholders Equity FY 2024 · Sep 30, 2023 $145.63M
Stockholders Equity FY 2024 · Sep 30, 2022 $167.12M
Current Liabilities FY 2024 · Sep 30, 2024 $3.3M
Current Liabilities FY 2024 · Sep 30, 2023 $3.5M
Total Liabilities FY 2024 · Sep 30, 2024 $3.51M
Total Liabilities FY 2024 · Sep 30, 2023 $3.5M
Current Assets FY 2024 · Sep 30, 2024 $127.56M
Current Assets FY 2024 · Sep 30, 2023 $148.8M
Total Assets FY 2024 · Sep 30, 2024 $128.11M
Total Assets FY 2024 · Sep 30, 2023 $149.12M
Eps Diluted FY 2024 · Sep 30, 2024 −$0.64
Eps Diluted FY 2024 · Sep 30, 2023 −$0.60
Eps Basic FY 2024 · Sep 30, 2024 −$0.64
Eps Basic FY 2024 · Sep 30, 2023 −$0.60
Sga Expense FY 2024 · Sep 30, 2024 $13.21M
Sga Expense FY 2024 · Sep 30, 2023 $10.81M
Rd Expense FY 2024 · Sep 30, 2024 $21.21M
Rd Expense FY 2024 · Sep 30, 2023 $21.32M
Net Income FY 2024 · Sep 30, 2024 −$28.54M
Net Income FY 2024 · Sep 30, 2023 −$26.58M